Literature DB >> 21769124

Parkinson disease: Poor results for retinal cell transplants in Parkinson disease.

M Angela Cenci, Håkan Widner.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21769124     DOI： 10.1038/nrneurol.2011.111

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  8 in total

1.  Intrastriatal implantation of human retinal pigment epithelial cells attached to microcarriers in advanced Parkinson disease.

Authors:  Natividad P Stover; Roy A E Bakay; Thyagarajan Subramanian; Cathy D Raiser; Michael L Cornfeldt; Alfred W Schweikert; Richard C Allen; Ray L Watts
Journal:  Arch Neurol       Date:  2005-12

2.  Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson's disease: a double-blind, randomised, controlled trial.

Authors:  Robert E Gross; Raymond L Watts; Robert A Hauser; Roy Ae Bakay; Heinz Reichmann; Rüdiger von Kummer; William G Ondo; Elke Reissig; Wilhelm Eisner; Heike Steiner-Schulze; Harald Siedentop; Klaus Fichte; Walter Hong; Michael Cornfeldt; Katherine Beebe; Rupert Sandbrink
Journal:  Lancet Neurol       Date:  2011-05-10       Impact factor: 44.182

3.  PET imaging of implanted human retinal pigment epithelial cells in the MPTP-induced primate model of Parkinson's disease.

Authors:  D J Doudet; M L Cornfeldt; C R Honey; A W Schweikert; R C Allen
Journal:  Exp Neurol       Date:  2004-10       Impact factor: 5.330

4.  Striatal xenotransplantation of human retinal pigment epithelial cells attached to microcarriers in hemiparkinsonian rats ameliorates behavioral deficits without provoking a host immune response.

Authors:  Thyagarajan Subramanian; Deanna Marchionini; Elizabeth M Potter; Michael L Cornfeldt
Journal:  Cell Transplant       Date:  2002       Impact factor: 4.064

Review 5.  Animal models of neurological deficits: how relevant is the rat?

Authors:  M Angela Cenci; Ian Q Whishaw; Timothy Schallert
Journal:  Nat Rev Neurosci       Date:  2002-07       Impact factor: 34.870

6.  Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions.

Authors:  Christopher G Goetz; Joanne Wuu; Michael P McDermott; Charles H Adler; Stanley Fahn; Curt R Freed; Robert A Hauser; Warren C Olanow; Ira Shoulson; P K Tandon; Sue Leurgans
Journal:  Mov Disord       Date:  2008-04-15       Impact factor: 10.338

7.  Characterization and survival of long-term implants of human retinal pigment epithelial cells attached to gelatin microcarriers in a model of Parkinson disease.

Authors:  Joseph Flores; Ivan L Cepeda; Michael L Cornfeldt; John R O'Kusky; Doris J Doudet
Journal:  J Neuropathol Exp Neurol       Date:  2007-07       Impact factor: 3.685

8.  Human retinal pigment epithelial cell implants ameliorate motor deficits in two rat models of Parkinson disease.

Authors:  Ivan L Cepeda; Joseph Flores; Michael L Cornfeldt; John R O'Kusky; Doris J Doudet
Journal:  J Neuropathol Exp Neurol       Date:  2007-07       Impact factor: 3.685
  8 in total
  1 in total

1.  Intrastriatal transplantation of retinal pigment epithelial cells for the treatment of Parkinson disease: in vivo longitudinal molecular imaging with 18F-P3BZA PET/CT.

Authors:  Lihong Bu; Renfei Li; Hongguang Liu; Wei Feng; Xiaoxing Xiong; Heng Zhao; Douglas Vollrath; Baozhong Shen; Zhen Cheng
Journal:  Radiology       Date:  2014-04-20       Impact factor: 11.105
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.